# BAFNAPH — Bafna Pharmaceuticals Limited

> Bafna Pharmaceuticals Limited (BAFNAPH) on the NSE: 1,437 sessions of split-adjusted history from 2020.

Canonical: https://patternsradar.com/s/BAFNAPH

## Latest session

- Close: 242.45 INR (2% on the day), 2026-08-21
- Delivery: 100% of volume taken to demat (20-day average 100%)
- Volume: 23.7K shares, turnover ₹57.4L
- Relative volume: 0.61× of its own 20-day average

## Technicals

- RSI(14): 46.42
- ATR(14): 5.94
- SMA 50: 225.33, SMA 200: 158.46
- 52-week range: 91.2 – 290.7 (-16.6% from the high)

## Performance

- 1 week -5.92%, 1 month -0.23%, 3 months 79.55%
- 6 months 103.31%, 1 year 143.72%

## Fundamentals

- Market cap: 573.5 crore
- P/E (TTM): 73.66 — NULL when trailing earnings are negative or unfiled, never a misleading number
- EPS (TTM): 3.29 INR, split-adjusted to match the price series
- Revenue growth: -23.22% YoY, -37.07% QoQ
- Profit growth: -97.78% YoY, -97.27% QoQ

Compound annual growth, trailing-twelve-month against the same measure N years earlier:

| Window | Revenue | Profit |
| --- | --- | --- |
| 2y | -0.43% | 433.75% |
| 3y | 0.52% | -21.87% |
| 4y | 15.25% | 15.16% |
| 5y | 13.48% | 5% |

## Quarterly results

Last 1 filed quarters, consolidated basis, in rupees crore as filed.

| Quarter | Revenue | Total expenses | Profit before tax | Net profit | EPS | Net margin |
| --- | --- | --- | --- | --- | --- | --- |
| 2020-03-31 | 13.1 | 9.4 | 2.2 | 0.3 | 0.2 | 2.42% |

A quarterly filing with NSE carries a profit and loss only. There is no balance sheet behind it, and so no debt, cash flow or return-on-capital figure in this dataset. EPS is restated onto the split-adjusted basis the price series uses; every rupee figure is exactly as filed.

## Shareholding

As filed for 2026-06-30:

- Promoter: 75%
- Public: 25%

Institutional and pledge percentages come from a filing stage whose backfill has reached about 1% of instruments, so they are absent here rather than zero.

## Recent filings

- 2026-08-11: results for 2026-06-30 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_185240_11082026182000_iXBRL_WEB.html
- 2026-07-20: shareholding for 2026-06-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1697196_20072026055342_WEB.xml
- 2026-05-29: results for 2026-03-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_164189_29052026210542_iXBRL_WEB.html
- 2026-04-21: shareholding for 2026-03-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1656190_21042026034659_WEB.xml
- 2026-02-11: results for 2025-12-31 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_142020_11022026180912_iXBRL_WEB.html
- 2026-01-19: shareholding for 2025-12-31 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1603841_19012026123808_WEB.xml
- 2025-11-11: results for 2025-09-30 standalone — https://nsearchives.nseindia.com/corporate/ixbrl/INTEGRATED_FILING_INDAS_126172_11112025190206_iXBRL_WEB.html
- 2025-10-16: shareholding for 2025-09-30 — https://nsearchives.nseindia.com/corporate/xbrl/SHP_1550234_16102025035215_WEB.xml

Dated by the day the company broadcast the filing. 50 events are indexed for this instrument.

## About the instrument

- Listed: 2020-03-02 — latest session 2026-08-21 (1,437 sessions)
- ISIN: INE878I01022
- Series: BE
- Liquidity rank: #1603 by 20-day average turnover — not index membership

Delivery figures come from NSE's daily reports and are unavailable for older sessions. Prices are end-of-day, split- and bonus-adjusted, from the eod2 dataset.

Charts and the full bar history are on the rendered page: https://patternsradar.com/s/BAFNAPH.